NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Earlier Blood Transfusion Timing for Heart Disease Patients After Surgery
TL;DR
Heart patients can gain a 41% lower risk of heart failure and irregular heartbeat by receiving blood transfusions earlier when hemoglobin drops below 10 g/dL after major surgery.
The TOP trial compared transfusing blood at hemoglobin levels below 10 g/dL versus below 7 g/dL in 1,424 veterans with heart disease undergoing major surgery.
Earlier blood transfusions for heart surgery patients may reduce cardiac strain and improve recovery outcomes, advancing personalized medical care for vulnerable populations.
Contrary to traditional thinking, giving more blood earlier may protect the heart better than waiting in high-risk surgical patients with heart disease.
Found this article helpful?
Share it with your network and spread the knowledge!
Earlier blood transfusions when hemoglobin drops below 10 g/dL after major surgery may be associated with a lower risk of irregular heartbeat and heart failure among people with heart disease, though it doesn't affect the risk of severe complications like death, heart attack, kidney failure, or stroke.
For people with heart disease, the risk of complications due to the strain of blood loss means that transfusion timing is critical, as persistent blood loss might place greater strain on the heart than the volume of blood transfused.
The study compared transfusing when hemoglobin drops below 10 g/dL versus the current standard of waiting until hemoglobin drops below 7 g/dL, finding that the earlier approach may reduce certain heart complications without affecting severe outcomes.
The study involved more than 1,400 U.S. military veterans having major general or vascular surgery, and the research was presented at the American Heart Association's Scientific Sessions 2025 in New Orleans.
Earlier transfusions were associated with lower risk of irregular heartbeat (arrhythmia) and heart failure, but not with reduced risk of death, heart attack, kidney failure, need for a heart procedure, or stroke.
The findings were simultaneously published in JAMA and presented on November 8, 2025, at the American Heart Association's Scientific Sessions in New Orleans.
Hemoglobin is a vital component of red blood cells that transports oxygen throughout the body, and maintaining adequate levels through transfusion timing may help reduce strain on the heart in patients with underlying heart disease.
Patients were monitored for complications until discharge or 30 days after surgery, whichever came first, with outcomes assessed 90 days after surgery.
Patients with heart disease undergoing major surgery should discuss transfusion timing with their healthcare team, as earlier transfusions may help reduce certain heart-related complications without increasing severe risks.
Curated from NewMediaWire
